HHL.TO vs. FINN.NEO

Last updated Jul 18, 2026

HHL.TO (Harvest Healthcare Leaders Income ETF) and FINN.NEO (Fidelity Global Innovators ETF) are both exchange-traded funds - HHL.TO is a Health & Biotech Equities fund actively managed by Harvest, while FINN.NEO is a Global Equities fund actively managed by Fidelity. Both are actively managed. Over the past 3 years, HHL.TO returned 5.77%/yr vs 40.06%/yr for FINN.NEO. At a 0.17 correlation, their price movements are largely independent. HHL.TO charges 0.85%/yr vs 1.09%/yr for FINN.NEO.

Performance

HHL.TO vs. FINN.NEO - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Harvest Healthcare Leaders Income ETF (HHL.TO) and Fidelity Global Innovators ETF (FINN.NEO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HHL.TO achieves a -2.24% return, which is significantly lower than FINN.NEO's 35.77% return.

HHL.TO

• 1D: -0.83%
• 1M: 5.41%
• 6M: -3.12%
• YTD: -2.24%
• 1Y: 11.62%
• 3Y*: 5.77%
• 5Y*: 5.76%
• 10Y*: 6.61%

FINN.NEO

• 1D: -1.71%
• 1M: -3.34%
• 6M: 28.06%
• YTD: 35.77%
• 1Y: 49.48%
• 3Y*: 40.06%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HHL.TO vs. FINN.NEO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
HHL.TO Harvest Healthcare Leaders Income ETF	-2.24%	10.47%	3.87%	5.47%
FINN.NEO Fidelity Global Innovators ETF	35.77%	20.61%	58.65%	21.40%

Correlation

The correlation between HHL.TO and FINN.NEO is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (All Time) Calculated using the full available price history since May 19, 2023	0.17

The correlation between HHL.TO and FINN.NEO shifts across timeframes, from 0.06 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.

Return for Risk

HHL.TO vs. FINN.NEO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HHL.TO

HHL.TO Risk / Return Rank: 25
HHL.TO Sharpe Ratio Rank: 26
HHL.TO Sortino Ratio Rank: 27
HHL.TO Omega Ratio Rank: 24
HHL.TO Calmar Ratio Rank: 24
HHL.TO Martin Ratio Rank: 22

FINN.NEO

FINN.NEO Risk / Return Rank: 80
FINN.NEO Sharpe Ratio Rank: 79
FINN.NEO Sortino Ratio Rank: 74
FINN.NEO Omega Ratio Rank: 76
FINN.NEO Calmar Ratio Rank: 89
FINN.NEO Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HHL.TO vs. FINN.NEO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harvest Healthcare Leaders Income ETF (HHL.TO) and Fidelity Global Innovators ETF (FINN.NEO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HHL.TO	FINN.NEO	Difference
Sharpe ratio: Return per unit of total volatility	0.75	2.01	-1.26
Sortino ratio: Return per unit of downside risk	1.24	2.67	-1.42
Omega ratio: Gain probability vs. loss probability	1.14	1.36	-0.21
Calmar ratio: Return relative to maximum drawdown	0.91	4.16	-3.26
Martin ratio: Return relative to average drawdown	2.02	12.96	-10.94

HHL.TO vs. FINN.NEO - Sharpe Ratio Comparison

The current HHL.TO Sharpe Ratio is 0.75, which is lower than the FINN.NEO Sharpe Ratio of 2.01. The chart below compares the historical Sharpe Ratios of HHL.TO and FINN.NEO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

HHL.TO vs. FINN.NEO - Drawdown Comparison

The maximum HHL.TO drawdown since its inception was -26.70%, roughly equal to the maximum FINN.NEO drawdown of -25.66%. Use the drawdown chart below to compare losses from any high point for HHL.TO and FINN.NEO.

Drawdown Indicators

	HHL.TO	FINN.NEO	Difference
Max Drawdown Largest peak-to-trough decline	-26.70%	-25.66%	-1.04%
Max Drawdown (1Y) Largest decline over 1 year	-12.88%	-11.94%	-0.94%
Max Drawdown (3Y) Largest decline over 3 years	-16.01%	-25.66%	+9.65%
Max Drawdown (5Y) Largest decline over 5 years	-16.01%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-26.70%	—	—
Current Drawdown Current decline from peak	-5.43%	-6.49%	+1.06%
Average Drawdown Average peak-to-trough decline	-6.23%	-3.98%	-2.25%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.76%	3.83%	+1.93%

Volatility

HHL.TO vs. FINN.NEO - Volatility Comparison

The current volatility for Harvest Healthcare Leaders Income ETF (HHL.TO) is 5.75%, while Fidelity Global Innovators ETF (FINN.NEO) has a volatility of 6.48%. This indicates that HHL.TO experiences smaller price fluctuations and is considered to be less risky than FINN.NEO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HHL.TO	FINN.NEO	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.75%	6.48%	-0.73%
Volatility (6M) Calculated over the trailing 6-month period	11.55%	20.24%	-8.69%
Volatility (1Y) Calculated over the trailing 1-year period	15.51%	24.76%	-9.25%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.35%	22.40%	-8.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.84%	22.40%	-6.56%

HHL.TO vs. FINN.NEO - Expense Ratio Comparison

HHL.TO has a 0.85% expense ratio, which is lower than FINN.NEO's 1.09% expense ratio.

Dividends

HHL.TO vs. FINN.NEO - Dividend Comparison

HHL.TO's dividend yield for the trailing twelve months is around 10.07%, while FINN.NEO has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FINN.NEO Fidelity Global Innovators ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
HHL.TO Harvest Healthcare Leaders Income ETF	10.07%	9.36%	9.27%	8.71%	8.51%	7.91%	9.02%	8.65%	9.00%	8.45%	8.83%	8.19%

Frequently Asked Questions

Can I hold both HHL.TO and FINN.NEO in my portfolio?

HHL.TO and FINN.NEO have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, HHL.TO or FINN.NEO?

On fees, HHL.TO is cheaper at 0.85% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, HHL.TO or FINN.NEO?

HHL.TO is cheaper with a 0.85% expense ratio, compared with 1.09% for FINN.NEO.

What is the main difference between HHL.TO and FINN.NEO?

HHL.TO is categorized as Health & Biotech Equities, while FINN.NEO is Global Equities. They also come from different issuers: Harvest and Fidelity. Their fees differ too: 0.85% for HHL.TO and 1.09% for FINN.NEO.